Growth Metrics

Biodesix (BDSX) Gains from Investment Securities (2019 - 2025)

Biodesix's Gains from Investment Securities history spans 7 years, with the latest figure at -$159000.0 for Q4 2025.

  • For Q4 2025, Gains from Investment Securities fell 122.14% year-over-year to -$159000.0; the TTM value through Dec 2025 reached $604000.0, down 59.79%, while the annual FY2025 figure was $157000.0, 24.52% down from the prior year.
  • Gains from Investment Securities reached -$159000.0 in Q4 2025 per BDSX's latest filing, down from $6.9 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $6.9 million in Q2 2025 to a low of -$900000.0 in Q4 2023.
  • Average Gains from Investment Securities over 5 years is $1.3 million, with a median of $718000.0 recorded in 2024.
  • Peak YoY movement for Gains from Investment Securities: crashed 409.28% in 2023, then skyrocketed 14698.58% in 2024.
  • A 5-year view of Gains from Investment Securities shows it stood at $2.3 million in 2021, then plummeted by 87.28% to $291000.0 in 2022, then plummeted by 409.28% to -$900000.0 in 2023, then soared by 179.78% to $718000.0 in 2024, then plummeted by 122.14% to -$159000.0 in 2025.
  • Per Business Quant, the three most recent readings for BDSX's Gains from Investment Securities are -$159000.0 (Q4 2025), $6.9 million (Q2 2025), and $45000.0 (Q1 2025).